The beat-and-raise quarter with accelerating revenue growth, margin expansion, and strong cash flow supports a bullish thesis. Watch for continued same-store discharge trends and de novo hospital openings as catalysts. The raised guidance midpoint implies ~7% revenue growth and ~7% adjusted EBITDA growth for the remainder of 2026.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 1 $107.38entry
- T+1 · 7mo ago −1.03%α −0.69% · $106.27
- T+5 · 6mo ago −1.16%α −3.51% · $106.13
- T+20 · 6mo ago −4.83%α −10.10% · $102.19
- T+60 · 4mo ago +6.05%α +3.49% · $113.88
Price Chart
How similar events traded
Executive Summary
Encompass Health reported Q1 2026 results with net operating revenue of $1.5866B (+9.0% YoY) and GAAP diluted EPS from continuing operations of $1.77 (+19.6% YoY), beating consensus estimates of $1.51 EPS and $1.57B revenue. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted EPS, signaling continued operational momentum and capacity expansion.
Key Financial Metrics
Key Facts
- Q1 2026 net operating revenue $1.5866B, up 9.0% YoY from $1.4554B
- GAAP diluted EPS from continuing operations $1.77, up 19.6% YoY from $1.48
- Adjusted EPS $1.60, up 16.8% YoY from $1.37
- Adjusted EBITDA $348.8M, up 11.2% YoY from $313.6M
- Full-year 2026 guidance raised: revenue to $6.375B-$6.470B (from $6.365B-$6.465B), Adjusted EBITDA to $1.350B-$1.380B (from $1.340B-$1.380B), adjusted EPS to $5.89-$6.11 (from $5.81-$6.10)
- Total discharges up 4.3% YoY to 67,763; same-store discharge growth 1.6%
- Net patient revenue per discharge $22,633, up 3.7% YoY
- Repurchased 707,965 shares for $71.6M in Q1; $261M remaining under buyback authorization
- Net leverage 1.9x; amended credit agreement extended to March 2031
- Opened 49-bed hospital in Irmo, SC; added 44 beds to existing hospitals
Financial Impact
Revenue beat consensus by ~$16.6M (1.06%); EPS beat consensus by $0.26 (17.2%)
Risk Factors
- Same-store discharge growth decelerated to 1.6% from 4.4% in Q1 2025, signaling potential market saturation or competitive pressure
- Adjusted free cash flow declined 12.9% YoY to $193.8M due to higher working capital and maintenance capex
- Medicaid supplemental payments contributed $15.3M to other revenue, including $4.9M from prior periods, not fully recurring
- Provider tax expenses increased $9.7M YoY, pressuring margins
- RCD and TEAM regulatory programs introduce reimbursement uncertainty for Medicare patients
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000785161-26-000128 |
| Document: ehcq12026earningsslides_.htm | 0000785161-26-000128 |
| Document: ehc-20260430.htm | 0000785161-26-000128 |
| Document: 0000785161-26-000128-index-headers.html | 0000785161-26-000128 |
| Document: 0000785161-26-000128-index.html | 0000785161-26-000128 |
| Document: 0000785161-26-000128.txt | 0000785161-26-000128 |
| 8-K Data (Synthetic) | 0000785161-26-000128 |
Track record
14 reports on EHC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +8.88% at T+60 after the Aug 5, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago 8-K Neutral 4/10 Entry $137.54 to $141.15 Now $142.11 +3.32% ▲ +2.62% +0.26% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 No price data
- Oct 28, 202619d ago Press Release Bullish 6/10 Entry $131.49 to $135.90 Now $142.11 +8.08% ▲ +3.35% +5.13% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $122.09 to $131.49 Now $142.11 +16.40% ▲ +7.70% +8.08% vs SPY
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $124.09 to $124.10 Now $142.11 +14.52% ▲ +0.01% −0.70% vs SPY
- Oct 22, 202625d ago Press Release Neutral 2/10 Entry $126.01 to $124.09 Now $142.11 +12.78% ▼ −1.52% −1.00% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $119.80 to $120.97 Now $142.11 +18.62% ▲ +0.98% +0.30% vs SPY
- Sep 1, 202610w ago Insider Cluster Neutral 3/10 Entry $122.05 to $121.18 Now $142.11 +16.44% ▼ −0.71% −1.16% vs SPY
- Aug 11, 202613w ago Insider Cluster Bearish 5/10 Entry $125.35 to $124.83 Now $142.11 −13.37% ▲ +0.41% +0.67% vs SPY
- Aug 5, 202614w ago Press Release Bullish 7/10 Entry $124.82 to $125.23 Now $142.11 +13.85% ▲ +0.33% −0.28% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers